[REGULATION OF THE mTOR SIGNALING PATHWAY IN MACROPHAGES IN VARIOUS PATHOLOGIES]

Area of Science:

• Immunology
• Neuroscience
• Oncology

Background:

• Macrophages are crucial immune cells involved in defense, tissue repair, and coordinating immune responses.
• Inflammation involves two stages: a cytotoxic M1 macrophage phase for defense and an M2 phase for repair.
• Tumor-associated macrophages (TAMs) and microglia in the central nervous system (CNS) play distinct roles in disease progression.

Purpose of the Study:

• To investigate the differential effects of rapamycin on tumor-associated macrophages and CNS microglia.
• To explore rapamycin's potential to modulate macrophage phenotypes (M1/M2) for therapeutic benefit.

Main Methods:

• The study investigates the impact of rapamycin, an mTOR suppressor, on macrophage polarization.
• Comparative analysis of rapamycin's effects on macrophages in tumor microenvironments and microglial cells within the CNS.

Main Results:

• Rapamycin induces M1 polarization in tumor-associated macrophages, promoting tumor regression.
• In contrast, rapamycin promotes M2 polarization in microglial cells, potentially beneficial for neurodegenerative diseases and aging.

Conclusions:

• Rapamycin exhibits context-dependent immunomodulatory effects, targeting macrophage phenotypes differently in cancer and neurodegeneration.
• These findings suggest rapamycin as a potential therapeutic agent with distinct mechanisms in oncology and neurology.